Investment trust analysts at Stifel have downgraded the Woodford Patient Capital Trust from 'buy' to 'hold' on concerns about the overlap of its holdings with the suspended Equity Income fund and the impact dwindling investor support could have on the trust.
In a note, Stifel analysts Iain Scouller and Anthony Stern said one of the key concerns is around the overlap of holdings between the fund (WEIF) and the trust (WPCT), in the event of continued redemptions or in an extreme scenario if the fund is "forced to move into run-off". The duo calculated that 26% of the trust's NAV is held in listed companies that are also constituents of the open-ended fund, while 64% of the unlisted companies in the trust are also held by the fund. They added: "In an unusual transaction in March, WPCT acquired five unlisted companies for a total of £72.9m fr...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes